RAGONESE, Marta
 Distribuzione geografica
Continente #
EU - Europa 3.264
NA - Nord America 2.678
AS - Asia 1.515
SA - Sud America 490
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 54
OC - Oceania 2
Totale 8.166
Nazione #
US - Stati Uniti d'America 2.603
RU - Federazione Russa 1.862
SG - Singapore 603
CN - Cina 454
BR - Brasile 420
IE - Irlanda 306
SE - Svezia 276
IT - Italia 259
HK - Hong Kong 163
DE - Germania 127
FR - Francia 95
GB - Regno Unito 93
VN - Vietnam 77
PL - Polonia 71
FI - Finlandia 54
IN - India 46
UA - Ucraina 34
BD - Bangladesh 29
CA - Canada 28
JP - Giappone 25
MX - Messico 25
AR - Argentina 24
AT - Austria 24
IQ - Iraq 23
NL - Olanda 18
CO - Colombia 16
ID - Indonesia 15
TR - Turchia 15
ZA - Sudafrica 15
PK - Pakistan 11
ES - Italia 10
VE - Venezuela 9
KE - Kenya 8
JM - Giamaica 7
MA - Marocco 7
PE - Perù 7
UZ - Uzbekistan 7
BE - Belgio 6
EC - Ecuador 6
MY - Malesia 6
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JO - Giordania 4
NP - Nepal 4
TN - Tunisia 4
AL - Albania 3
CR - Costa Rica 3
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.004
Città #
Ashburn 514
Moscow 483
Singapore 330
Dublin 305
Dallas 240
Chandler 194
Nyköping 173
San Jose 169
Hong Kong 160
Beijing 155
Messina 112
The Dalles 103
Jacksonville 75
Council Bluffs 73
Los Angeles 69
Warsaw 69
Munich 67
New York 63
Lauterbourg 47
Princeton 43
Medford 42
São Paulo 41
Lancaster 40
Dearborn 35
Cambridge 29
Tianjin 27
Des Moines 26
Buffalo 24
Santa Clara 23
Brooklyn 20
Orem 20
Ho Chi Minh City 19
Tokyo 19
Vienna 19
Ann Arbor 18
Frankfurt am Main 18
Redondo Beach 18
Shenyang 18
Boardman 17
Helsinki 17
Hanoi 15
Seattle 14
London 13
Columbus 12
Guangzhou 12
Rome 12
Wilmington 12
Baghdad 11
Jinan 11
Nanjing 11
Rio de Janeiro 11
Belo Horizonte 10
Brasília 10
Denver 10
Hyderabad 10
Pune 10
Shenzhen 10
Amsterdam 9
Atlanta 9
Catania 9
Johannesburg 9
Mexico City 9
Bogotá 8
Jakarta 8
Manchester 8
Nairobi 8
Nanchang 8
San Mateo 8
Turku 8
Chennai 7
Chicago 7
Düsseldorf 7
Montreal 7
Nuremberg 7
Phoenix 7
Stockholm 7
Tashkent 7
Toronto 7
Boston 6
Campinas 6
Curitiba 6
Dong Ket 6
Haikou 6
Hangzhou 6
Lappeenranta 6
Milan 6
Woodbridge 6
Biên Hòa 5
Changsha 5
Faisalabad 5
Hillsboro 5
Houston 5
Joinville 5
Lima 5
Mumbai 5
Poplar 5
Shanghai 5
São Gonçalo 5
São José do Rio Preto 5
Abidjan 4
Totale 4.410
Nome #
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 314
Effects of cyberknife radiotherapy treatment of pituitary adenomas 296
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 252
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 208
A case of clinically silent acromegaly with erectile dysfunction. 198
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 195
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 181
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 179
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 179
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 178
Increased prevalence of acromegaly in a highly polluted area. 175
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 172
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 169
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 167
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 167
Course of pregnancies in women with Cushing's disease treated by gamma-knife 165
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 164
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 161
Predictive markers of recurrence in radically resected pituitary macroadenomas 160
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 158
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 158
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 157
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 153
Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women with Hashimoto's Thyroiditis 152
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 152
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 152
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 151
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 148
Thyroid nodules in growth hormone replaced patients. 146
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 144
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 144
How to improve effectiveness of pegvisomant treatment in acromegalic patients 143
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 137
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 137
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 135
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 133
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 133
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 129
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 112
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 107
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 106
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 101
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 97
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 97
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 96
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 93
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 93
Valutazione della morfologia e funzionalità tiroidea in pazienti acromegalici 92
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 89
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 89
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 85
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 83
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 82
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 80
Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes 77
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients 35
null 35
null 27
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 26
Adverse hepato-biliary-pancreatic events in acromegaly patients treated with first generation somatostatin receptor ligands 11
Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control 7
Preconception body mass index and maternal thyroid function: a longitudinal observational study 4
Totale 8.166
Categoria #
all - tutte 25.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 58 5 13 7 5 9 17 3 52 38 98
2022/2023865 81 87 47 48 44 82 31 27 358 8 43 9
2023/2024292 20 44 15 28 29 70 9 29 0 13 2 33
2024/20251.403 21 32 57 83 99 43 47 276 293 98 132 222
2025/20264.234 224 241 282 252 362 917 514 559 548 179 74 82
2026/2027378 79 299 0 0 0 0 0 0 0 0 0 0
Totale 8.166